Results 81 to 90 of about 90,671 (304)

Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis

European Heart Journal, 2020
Aims  Myocardial fibrosis (MF) might represent a key player in pathophysiology of heart failure in aortic stenosis (AS). We aimed to assess its impact on left ventricular (LV) remodelling, recovery, and mortality after transcatheter aortic valve ...
M. Puls, B. Beuthner, R. Topci, A. Vogelgesang, A. Bleckmann, Maren Sitte, T. Lange, S. Backhaus, A. Schuster, T. Seidler, I. Kutschka, K. Toischer, E. Zeisberg, C. Jacobshagen, G. Hasenfuss   +14 more
semanticscholar   +1 more source

Left Ventricular Outflow Tract Geometry as a Predictor of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation Using the Evolut Series

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Predicting the need for permanent pacemaker implantation (PPM) after transcatheter aortic valve implantation (TAVI) is crucial for procedural planning and patient counseling. Aims To evaluate whether left ventricular outflow tract (LVOT) morphology, specifically a tapered configuration, predicts conduction disturbances requiring PPM
Mahmoud Abdelshafy, Angela McInerney, Ahmed Elmeanawy, Paolo Alberto Del Sole, Max Wagener, Hatem Helal, Mahmoud Abozaid, Ashraf Alamir, Tamer Fouad, Alsayed Almarghany, Briain MacNeill, Osama Soliman, Darren Mylotte, Mohammad Abdelghani   +13 more
wiley   +1 more source

Allegra Transcatheter Heart Valve inside a Degenerated Sutureless Aortic Bioprosthesis

The Thoracic & Cardiovascular Surgeon Reports, 2021
Transcatheter aortic valve-in-valve implantation (VIV) is increasingly being used to successfully treat degenerated surgical aortic valve bioprostheses (SAVs).
Maximilian Vondran, Bernd Abt, Holger Nef, Ardawan J. Rastan   +3 more
doaj   +1 more source

Prediction of paravalvular leakage after transcatheter aortic valve implantation [PDF]

, 2015
Significant paravalvular leakage (PVL) after transcatheter aortic valve implantation (TAVI) is related to patient mortality. Predicting the development of PVL has focused on computed tomography (CT) derived variables but literature targeting CoreValve ...
Di Biase, M. (Matteo), Di Martino, L.F.M. (Luigi F. M.), Geleijnse, M.L. (Marcel), Jaegere, P.P.T. (Peter) de, Mieghem, N.M. (Nicolas) van, Ren, B. (Ben), Schultz, C. (Carl), Soliman, O.I.I. (Osama Ibrahim Ibrahim), Vletter, W.B. (Wim)   +8 more
core   +2 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

A Mobile Thrombus Adhering to an Intra-Annular Self-Expanding Transcatheter Aortic Valve

JACC: Case Reports
An 81-year-old woman who had undergone transcatheter aortic valve implantation 3 months earlier underwent routine follow-up transthoracic echocardiography, which revealed a mobile thrombus adhering to the bioprosthetic valve.
Naoki Nishiura, MD, Yasushi Fuku, MD, Atsushi Sakata, MD, Takeshi Maruo, MD, PhD, Kazushige Kadota, MD, PhD   +4 more
doaj   +1 more source

Baseline ECG and Prognosis After Transcatheter Aortic Valve Implantation: The Role of Interatrial Block

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background The clinical significance of conduction disturbances after transcatheter aortic valve implantation has been described; however, little is known about the influence of baseline ECGs in the prognosis of these patients.
Lourdes Vicent, Clara Fernández‐Cordón, Luis Nombela‐Franco, Luis Alberto Escobar‐Robledo, Ana Ayesta, Albert Ariza Solé, Juan José Gómez‐Doblas, Eva Bernal, Gabriela Tirado‐Conte, Javier Cobiella, Hugo González‐Saldivar, Diego López‐Otero, Pablo Díez‐Villanueva, Fernando Sarnago, Xavier Armario, Antonio Bayés‐de-Luna, Manuel Martínez‐Sellés   +16 more
doaj   +1 more source

Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress–Induced, Piezo-1–Mediated Monocyte Activation

Circulation, 2020
Supplemental Digital Content is available in the text. Background: Aortic valve stenosis is an increasingly prevalent degenerative and inflammatory disease. Transcatheter aortic valve implantation (TAVI) has revolutionized its treatment, thereby avoiding
S. Baratchi, M. Zaldivia, M. Wallert, Julia Loseff-Silver, Sefaa Al-aryahi, J. Zamani, P. Thurgood, Agus Salim, N. Htun, D. Stub, P. Vahidi, S. Duffy, A. Walton, T. H. Nguyen, A. Jaworowski, K. Khoshmanesh, K. Peter   +16 more
semanticscholar   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Updates on transcatheter aortic valve replacement: Techniques, complications, outcome, and prognosis

Journal of the Saudi Heart Association, 2018
Transcatheter aortic valve replacement (TAVR) initially emerged as a therapeutic option for high-risk patients with severe aortic stenosis. Advancement in technologies since the first era of TAVRs, experience from previous obstacles, and lessons learned ...
Jarrah Alfadhli, Mohammed Jeraq, Vikas Singh, Claudia Martinez   +3 more
doaj   +1 more source